Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 4, 2011, Pages 879-887

  Wu, Hongju ^a   Xin, Yan ^a   Zhao, Jing ^a   Sun, Dan ^a   Li, Wenhui ^a   Hu, Yueyun ^a   Wang, Shasha ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Docetaxel; Gastric cancer; Metronomic chemotherapy

Indexed keywords

CD31 ANTIGEN; DOCETAXEL; THROMBOSPONDIN 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOPENIA; LOW DRUG DOSE; MAXIMUM TOLERATED DOSE; METRONOMIC CHEMOTHERAPY; MICROVASCULATURE; MICROVESSEL DENSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROVESSELS; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TAXOIDS; UMBILICAL VEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054747516     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1563-6     Document Type: Article

References (29)

1. A Albert 2008 New drugs in the treatment of gastric tumors Clin Transl Oncol 10 256 261 10.1007/s12094-008-0194-9
2. A Ooyama T Oka HY Zhao M Yamamoto S Akiyama M Fukushima 2008 Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts Cancer Lett 267 26 36 18420342 10.1016/j.canlet.2008.03.008 1:CAS:528:DC%2BD1cXotlCgtbY%3D
3. L Orlando A Cardillo A Rocca, et al. 2006 Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer Anticancer Drugs 17 961 967 16940806 10.1097/01.cad.0000224454.46824.fc 1:CAS:528:DC%2BD28XovVWjtL8%3D (Pubitemid 44350615)
4. OG Scharovsky LE Mainetti VR Rozados 2009 Metronomic chemotherapy is changing the paradigm that more is better Curr Oncol 16 7 15 19370174 10.3747/co.v16i2.420 1:STN:280:DC%2BD1M3otVartA%3D%3D
5. ED Tetzlaff JD Cheng JA Ajani 2008 Review of docetaxel in the treatment of gastric cancer Ther Clin Risk Manag 4 999 1007 19209281 1:CAS:528: DC%2BD1cXhsFers7zP
6. R Benelli S Monteghirfo C Balbi, et al. 2009 Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player Int J Cancer 124 2989 2996 19319982 10.1002/ijc.24305 1:CAS:528:DC%2BD1MXltlCgur8%3D
7. G Bocci A Falcone A Fioravanti, et al. 2008 Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib Br J Cancer 98 1619 1629 18443598 10.1038/sj.bjc.6604352 1:CAS:528:DC%2BD1cXlvVWhsb0%3D (Pubitemid 351684682)
8. TG Liu Y Huang D Cui, et al. 2009 Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice statistical analysis BMC Cancer 9 250 19624862 10.1186/1471-2407-9-250
9. AA Kamat TJ Kim CN Landen, et al. 2007 Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer Cancer Res 67 281 288 17210709 10.1158/0008-5472.CAN-06-3282 1:CAS:528:DC%2BD2sXisFSltw%3D%3D (Pubitemid 46142786)
10. RS Kerbel BA Kamen 2004 The anti-angiogenic basis of metronomic chemotherapy Nat Rev Cancer 4 423 436 15170445 10.1038/nrc1369 1:CAS:528:DC%2BD2cXksVaisbk%3D (Pubitemid 38745528)
11. G Bocci KC Nicolaou RS Kerbel 2002 Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs Cancer Res 62 6938 6943 12460910 1:CAS:528:DC%2BD38XpsVahsLg%3D (Pubitemid 35424084)
12. J Lawler 2002 Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth J Cell Mol Med 6 1 12 12003665 10.1111/j.1582-4934.2002. tb00307.x 1:CAS:528:DC%2BD38XksVCjt74%3D (Pubitemid 44133979)
13. DW Dawson SF Pearce R Zhong RL Silverstein WA Frazier NP Bouck 1997 CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells J Cell Biol 138 707 717 9245797 10.1083/jcb.138.3.707 1:CAS:528: DyaK2sXltlKhs7g%3D (Pubitemid 27349849)
14. N Guo HC Krutzsch JK Inman DD Roberts 1997 Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells Cancer Res 57 1735 1742 9135017 1:CAS:528:DyaK2sXjtFelsbY%3D (Pubitemid 27199668)
15. B Jiménez OV Volpert SE Crawford M Febbraio RL Silverstein N Bouck 2000 Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nat Med 6 41 48 10613822 10.1038/71517 (Pubitemid 30048524)
16. JE Damber C Vallbo P Albertsson B Lennernas K Norrby 2006 The antitumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin Cancer Chemother Pharmacol 58 354 360 16333676 10.1007/s00280-005-0163-8 1:CAS:528:DC%2BD28XkvFOju7c%3D (Pubitemid 43800739)
17. B Laquente C Lacasa MM Ginestà O Casanovas A Figueras M Galán IG Ribas JR Germà G Capellà F Viñals 2008 Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model Mol Cancer Ther 7 638 647 18347150 10.1158/1535-7163.MCT- 07-2122 1:CAS:528:DC%2BD1cXjtlWgsro%3D (Pubitemid 351482146)
18. G Bocci G Francia S Man J Lawler RS Kerbel 2003 Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy Proc Natl Acad Sci USA 100 12917 12922 14561896 10.1073/pnas.2135406100 1:CAS:528:DC%2BD3sXoslKnu7g%3D (Pubitemid 37340000)
19. H Bando 2007 Vascular endothelial growth factor and bevacitumab in breast cancer Breast Cancer 14 163 173 17485901 10.2325/jbcs.968
20. DF Hayes K Miller G Sledge 2007 Angiogenesis as targeted breast cancer therapy Breast 16 Suppl 2 S17 S19 17707641 10.1016/j.breast.2007.07.003 (Pubitemid 350028550)
21. M Colleoni A Rocca MT Sandri, et al. 2002 Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Ann Oncol 13 73 80 11863115 10.1093/annonc/mdf013 1:STN:280:DC%2BD387islyksw%3D%3D
22. M Colleoni L Orlando G Sanna, et al. 2006 Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects Ann Oncol 17 232 238 16322118 10.1093/annonc/mdj066 1:STN:280:DC%2BD28%2FjvVGksQ%3D%3D (Pubitemid 43160111)
23. P Correale D Cerretani C Remondo, et al. 2006 A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients Oncol Rep 16 133 140 16786136 1:CAS:528:DC%2BD28Xntlans7w%3D
24. G Bocci KC Nicolaou R Kerbel 2002 Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs Cancer Res 62 6938 6943 12460910 1:CAS:528:DC%2BD38XpsVahsLg%3D (Pubitemid 35424084)
25. C Magnon A Galaup V Rouffiac, et al. 2007 Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration Gene Ther 14 108 117 16943854 10.1038/sj.gt.3302901 1:CAS:528:DC%2BD2sXhsFOqsQ%3D%3D (Pubitemid 46043825)
26. RR Maria C Francesca G Francesca 2005 Microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma Int J Surg Pathol 13 135 142 10.1177/106689690501300202 (Pubitemid 40617540)
27. Y Ji K Hayashi Y Amoh, et al. 2007 The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer Anticancer Res 27 713 718 17465193 1:CAS:528:DC%2BD2sXltVKmsbo%3D (Pubitemid 46586972)
28. Q Zhang X Kang W Zhao 2006 Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma Biochem Biophys Res Commun 342 824 828 16499874 10.1016/j.bbrc.2006.02.044 1:CAS:528:DC%2BD28XitVKjtrk%3D (Pubitemid 43320472)
29. M Zhang W Tao S Pan, et al. 2009 Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts Anticancer Drugs 20 355 363 19318912 10.1097/CAD.0b013e3283299f36